Blindsight, the experimental vision-restoring implant by Elon Musk’s brain-chip startup, Neuralink, has received the U.S. Food and Drug Administration’s (FDA) "breakthrough device" designation, according to the company.

Neuralink has successfully implanted a chip in the brain of their first human patient earlier this week, as per Elon Musk, founder of the brain-chip startup.